The Life Science business of Merck KGaA, Darmstadt, Germany, to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
HUB Organoids official news RSS · Indexed industry source record · Source published: Tue Dec 17 2024 14:05:21 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fastest growing cell culture segment; hold potential to speed up drug development, reduce animal testing Darmstadt, Germany, December 17, 2024 – The Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, […] The po
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.